Jena Stephens, MD
Urology · Oklahoma City, OKNPI 1063077683
Payments from drug & device makers
Across 58 payments — averaging $82.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$3K
- Boston Scientific$947
- Teleflex LLC$280
- Procept Biorobotics Corporation$168
- Axonics, Inc.$151
- Coloplast$115
- plus $432 from 13 others
What the payments were for
- Travel & lodging$1,18425%
- Food & beverage$2,09344%
- Education$1,50031%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 5 | $2,684 |
| Boston Scientific | 22 | $947 |
| Teleflex LLC | 4 | $280 |
| Procept Biorobotics Corporation | 1 | $168 |
| Axonics, Inc. | 2 | $151 |
| Coloplast | 2 | $115 |
| Sumitomo Pharma America, Inc. | 5 | $86 |
| Myriad Genetic Laboratories, Inc. | 2 | $53 |
| Urogen Pharma, Inc. | 3 | $48 |
| Medtronic | 1 | $38 |
| Vertex | 2 | $35 |
| Tolmar, Inc. | 2 | $30 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
| Progenics Pharmaceuticals, Inc. | 1 | $22 |
| Endo USA, Inc. | 1 | $22 |
| Laborie Medical Technologies Corp. | 1 | $20 |
| AbbVie | 1 | $18 |
| Caldera Medical, Inc | 1 | $18 |
| Antares Pharma, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$1,500
- Da Vinci Surgical System$1,154
- Axonics$262
- AquaBeam Robotic System$168
- UroLift$163
- Solyx SIS System$153
- Bulkamid$117
- AMS 700$113
- GENERAL KIDNEY STONE DISEASE$104
How this compares
$4,777 in reported general payments places this provider in the 50th percentile of 145 urology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 35 | $18,994 |
| Estradiol | 12 | $716 |
| Tamsulosin Hcl | 80 | $605 |
| Solifenacin Succinate | 12 | $534 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 21 | $308 |
| Finasteride | 28 | $175 |
| Oxybutynin Chloride | 24 | $150 |
| Oxybutynin Chloride ErOxybutynin Chloride | 12 | $116 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 21 | $103 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $77 |
| Cephalexin | 19 | $72 |
Paid to pharmacies, not to this prescriber.
Other urology in Oklahoma City
- Kelly StrattonOklahoma City$1.9M
- Michael CooksonOklahoma City$658K
- Mohammad RamadanOklahoma City$215K
- Basel HassounOklahoma City$46K
- Sanjay PatelOklahoma City$40K
- Ashley BowenOklahoma City$32K
- Sardar Mohammad Khan GalzieOklahoma City$25K
- Dominic FrimbergerOklahoma City$24K
- Johnny HicksonOklahoma City$16K
- Andrew McIntoshOklahoma City$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.